Investorideas.com adds New IPOs in Biotech, Technology, Homebuilder, Aerospace, Sports; (Nasdaq: $AARD), (NASDAQ: $SION), (Nasdaq: $NNNN), (NASDAQ: $CJMB), (NASDAQ: $XHLD), (NASDAQ: $ODYS), (NYSE: $TTAM), (NASDAQ: $FBGL), (NYSE: $KRMN), (NASDAQ: $AGH)

 Investorideas.com adds New IPOs in Biotech, Technology, Homebuilder, Aerospace, Sports; (Nasdaq: $AARD), (NASDAQ: $SION), (Nasdaq: $NNNN), (NASDAQ: $CJMB), (NASDAQ: $XHLD), (NASDAQ: $ODYS), (NYSE: $TTAM), (NASDAQ: $FBGL), (NYSE: $KRMN), (NASDAQ: $AGH)  

 

 

 

March 7, 2025 – (Investorideas.com Newswire) Investorideas.com, a recognized top 100 investment site for stock news announces today’s IPO’s  to watch in the Biotech, Technology, Homebuilder, Aerospace and Sporting sectors.

 

New companies are all Nasdaq/NYSE IPOs from February 2025.

 

New stocks added today: Aardvark Therapeutics, Inc. (Nasdaq:AARD), Sionna Therapeutics, Inc. (NASDAQ:SION), Anbio Biotechnology (Nasdaq:NNNN), CALLAN JMB INC. (NASDAQ:CJMB), TEN Holdings, Inc. (NASDAQ:XHLD), Odysight.ai Inc. (NASDAQ:ODYS), Titan America SA (NYSE:TTAM), FBS Global Ltd  (NASDAQ:FBGL), Karman Holdings Inc. (NYSE:KRMN), Aureus Greenway Holdings Inc (NASDAQ:AGH).

 

Read this in full at https://www.investorideas.com/news/2025/main/03071Stocks.asp

 

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

New Stocks Added to the Biotech Directories:

Aardvark Therapeutics, Inc. (Nasdaq:AARD) is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its portfolio of small molecule programs targets biological pathways associated with alleviating hunger. Aardvark’s lead product candidate, ARD-101, targets Bitter Taste Receptors (TAS2Rs) expressed in the gut lumen, inducing secretion of endogenous signaling molecules, including the satiety hormone cholecystokinin (CCK), which in turn activates gut-brain signals to suppress the sensation of hunger. This potential first-in-class oral investigational drug demonstrated clinical activity and was well-tolerated in Phase 2 trials and has entered Phase 3 development for hyperphagia associated with Prader-Willi Syndrome, for which Aardvark has been granted Orphan Drug Designation. Additionally, Aardvark intends to advance ARD-101 into Phase 2 development for hyperphagia associated with hypothalamic obesity, with a goal of addressing significant unmet needs across both these rare disease indications. Aardvark is also developing ARD-201, which will be a fixed-dose combination of ARD-101 with a dipeptidyl peptidase-4 (DPP-4) inhibitor, with a goal of addressing some of the limitations of currently marketed GLP-1 therapies for the treatment of obesity and obesity-related conditions.

 

Sionna Therapeutics, Inc. (NASDAQ:SION) is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for CF by developing novel medicines that normalize the function of the CFTR protein. Sionna’s goal is to deliver differentiated medicines for people living with CF that can restore their CFTR function to as close to normal as possible by directly stabilizing CFTR’s nucleotide-binding domain 1 (NBD1), which the company believes is central to potentially unlocking dramatic improvements in clinical outcomes and quality of life for people with CF. Leveraging more than a decade of the co-founders’ research on NBD1, the company is advancing a pipeline of small molecules engineered to correct the defects caused by the F508del genetic mutation, which resides in NBD1. Sionna is also developing a portfolio of complementary CFTR modulators that are designed to work synergistically with its NBD1 stabilizers to improve CFTR function.

 

Anbio Biotechnology (Nasdaq:NNNN) is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. It is an innovation-driven global diagnostic company offering a diverse portfolio of mature diagnostic assays and five key platforms for biomarker detection, including Fluorescent Immunochromatographic Solution (FIA), Chemiluminescent Immunoassay Solution (ChLIA), Polymerase Chain Reaction Solution (PCR), Lateral Flow Assay Solution (LFIA), and Loop-Mediated Isothermal Amplification Solution (LAMP). These solutions cater to point-of-care settings, laboratory, and over-the-counter applications, enabling healthcare providers and patients to access fast, reliable, and cost-effective diagnostic tools. With a strong global presence across the EU, APAC, and the Americas, the Company’s Conformité Européenne (CE)-marked products detect biomarkers associated with critical medical domains, encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Designed for compatibility with multiple sample collection matrices, including serum, plasma, whole blood, feces, urine, and saliva, the product lineup facilitates efficient and reliable diagnostic testing across diverse patient populations and healthcare settings. By prioritizing innovation, affordability, and speed, Anbio aims to transform the global diagnostics landscape, fostering a paradigm shift towards personalized and decentralized diagnostic solutions.

 

CALLAN JMB INC. (NASDAQ:CJMB) is an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services to secure medical materials and protect patients and communities with compliant, safe, and effective medicines. Our combined expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance and emergency preparedness is unparalleled in the industry. We offer the Gold Standard in client experience with customizable interfaces, next-level reliability in shipping and environmental sustainability in our specialty packaging.

 

New Stocks Added to the Tech Directories:

TEN Holdings, Inc. (NASDAQ:XHLD) is a provider of event planning, production, and broadcasting services headquartered in Pennsylvania. The Company mainly produces virtual and hybrid events and physical events. Virtual and hybrid events involve virtual and hybrid event planning, production and broadcasting services, and continuing education services, all of which are supported by the Company's proprietary Xyvid Pro Platform. Physical events mainly involve live streaming and video recording of physical events.

 

Odysight.ai Inc. (NASDAQ:ODYS) is pioneering the Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) markets with its visualization and AI platform. Providing video sensor-based solutions for critical systems in the aviation, transportation, and energy industries, Odysight.ai leverages proven visual technologies and products from the medical industry. Odysight.ai’s unique video-based sensors, embedded software, and AI algorithms are being deployed in hard-to-reach locations and harsh environments across a variety of PdM and CBM use cases. Odysight.ai’s platform allows maintenance and operations teams visibility into areas which are inaccessible under normal operation, or where the operating ambience is not suitable for continuous real-time monitoring.

 

New Stocks Added to the Homebuilder Directories:

Titan America SA (NYSE:TTAM) is a leading vertically integrated, multi-regional manufacturer and supplier of heavy building materials and services operating primarily on the Eastern Seaboard of the United States. As a leading provider of materials that contribute to lower carbon emissions compared to traditional building materials, Titan America serves markets that benefit from population growth, economic growth, and technology and innovation trends that are among the strongest in the United States.

 

FBS Global Ltd  (NASDAQ:FBGL) provides construction and engineering services in Singapore. It undertakes interior fit-out works for institutional, residential, commercial, and industrial building projects. The company also supplies building materials and precast concrete components; recycles construction and industrial wastes; and offers pavement consultancy services.

 

New Stocks Added to the Aerospace Directories:

Karman Holdings Inc. (NYSE:KRMN) specialize in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs. Our integrated payload protection, propulsion, and interstage system solutions are deployed across a wide variety of existing and emerging programs supporting important Department of Defense and space sector initiatives

 

New Stocks Added to the Sporting Directories:

Aureus Greenway Holdings Inc (NASDAQ:AGH) owns and operates daily fee golf country clubs in the state of Florida that are designed to appeal to a wide-ranging population. The combination of our strategic locations and approachable golf-courses attracts both local and tourist demographics, allowing us to offer a variety of golf experiences while capturing a broad share of discretionary leisure spending. 

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter (X) https://X.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

 

800 665 0411

 

 

New Defense Stock Coming to Market-VisionWave Technologies Merger with Bannix Acquisition (NASDAQ: $BNIX)

 

New Defense Stock Coming to Market-VisionWave Technologies Merger with Bannix Acquisition (NASDAQ: $BNIX)  

 

Stocks Mentioned: (NASDAQ: $BNIX) (NYSE: $LMT) (NYSE: $GD), (NYSE: $LHX) (NYSE: $NOC)  

 

 

 

 

 

March 6, 2025 -   Investorideas.com, a top 100 investment site for 2025, releases a snapshot on defense stocks as global spending increases, and a new era of security emerges.    

 

According to the International Institute for Strategic Studies, “in 2024, global defense spending reflected intensifying security challenges and reached USD2.46 trillion, up from USD2.24trn the previous year.”

 

As President Trump calls for changes in defense spending, the world is adapting to the new reality that each country needs to build and expand on its own defense budget.

 

Shares of the top defense companies like Lockheed Martin (NYSE:LMT) General Dynamics (NYSE:GD), L3Harris Technologies (NYSE:LHX) and Northrop Grumman Corporation (NYSE:NOC) have stabilized after reaction to proposed defense cuts  and have since seen gains following the recent Trump-Zelenskyy meeting.

 

As defense budgets surge in Germany, France and other countries, some of top European defense stocks saw gains of up to 40% as investors traded on the sentiment of headlines.

 

In US markets, there is a new emerging defense technology company looking to go public.  Bannix Acquisition Corp. (NASDAQ: BNIX) recently filed an amended S-4 registration statement, with details of its target, VisionWave Technologies, Inc., coming into sharper focus. The filing outlines VisionWave’s business model, proprietary technology and commercialization strategy, providing insight into a company poised to revolutionize defense and security through AI-powered autonomous systems, radar technology, and advanced sensing solutions.

 

This news is paid news dissemination for Bannix Acquisition Corp.

 

Read this news, featuring BNIX in full at https://www.investorideas.com/news/2025/defense/03061VisionWave-Technologies.asp

 

VisionWave Technologies is an emerging defense technology company specializing in AI-driven solutions for military, homeland security and industrial applications. The company’s strategy is three-pronged:

 

          1.       Technology Licensing – VisionWave intends to license its proprietary AI and sensor technology to defense contractors and government agencies, enabling integration into existing military and security systems.

          2.       Direct Product Sales – The Company will manufacture and sell unmanned vehicles, remote weapon stations, and advanced radar systems directly to military, law enforcement, and industrial clients.

          3.       Strategic Partnerships – VisionWave is actively pursuing alliances and joint ventures with industry leaders to co-develop customized solutions based on its proprietary technology.

 

The company is transitioning from research and development (R&D) to full commercialization, with several pilot projects already underway.

 

VisionWave’s proprietary technology portfolio is built on AI-driven defense innovations, with key developments including:

 

1. Event-Based AI Vision Technology:

 

Inspired by biological vision systems, this AI-driven sensor technology allows real-time tracking of fast-moving or stealth objects, such as:

   •   Drones

   •   Mortars and rockets

   •   Bullets in mid-air

 

Unlike traditional thermal imaging, VisionWave’s event-based vision sensors process pixel-level changes, functioning like an AI-powered optical radar.

 

2. CoPilot AI: Fully Autonomous Drone Technology:

 

VisionWave’s CoPilot AI enables drones to operate autonomously, including:

   •   Intercepting incoming drones

   •   Executing swarm formations

   •   Adapting to mission requirements in real-time

 

This “fire-and-forget” AI-driven system outperforms human pilots in complex military and security scenarios.

 

3. Vision-RF: AI-Powered Radio Frequency Imaging:

 

One of VisionWave’s most groundbreaking innovations, Vision-RF can convert radio frequency (RF) signals into real-time images, allowing for:

   •   Aerial threat detection

   •   Through-wall visualization

   •   Underground activity monitoring

 

This technology is protected by multiple patents and has significant potential applications in defense, law enforcement, and infrastructure monitoring.

 

4. Remote Weapon Stations (RWS):

 

VisionWave has developed an advanced remote weapon system for combat vehicles and naval applications. This system:

   •   Enhances precision targeting

   •   Provides stabilization for better accuracy

   •   Integrates seamlessly into existing defense platforms

 

The company has already begun production in partnership with a U.S. military contractor, with full-scale manufacturing expected in 2025.

 

5. AI-Enabled Tactical Platforms:

 

VisionWave’s micro-ATV platform is designed for:

   •   Stealthy, high-mobility operations

   •   Law enforcement and Special Forces

   •   Medical evacuation and rapid response

 

This four-wheel-drive electric vehicle offers silent maneuverability, providing an edge over traditional gas-powered military transport.

 

VisionWave is at a critical inflection point, moving from prototype development to commercialization. The company has eight product lines, with several already at Technology Readiness Level (TRL) 7 or higher, meaning they are proven in operational environments.

 

Pilot projects with defense and homeland security agencies are actively being conducted and the company anticipates full-scale commercial production in 2025.

 

VisionWave faces competition from major defense contractors like Lockheed Martin, Northrop Grumman and Raytheon, as well as specialized drone defense firms such as Dedrone and Anduril Industries. However, the company’s proprietary AI-driven approach and patented technologies hopes to provide a strong competitive advantage.

 

Following a successful merger with Bannix Acquisition Corp, VisionWave will become a publicly traded company on NASDAQ under the ticker symbols:  VWAV (common stock) and

VWAVW (warrants).

 

VisionWave Technologies is positioning to be a next-generation defense technology firm with a strong focus on AI-driven military and security solutions. With proprietary radar, vision and autonomous technology, the company plans to disrupt traditional defense markets.

 

Commenting on the current state of the current evolving defense market, CEO of global financial advisory giant deVere Group opines,“ Almost every investor needs exposure to defense stocks amid shifting geopolitical realities.”

 

The comments from Nigel Green come as the Stoxx Europe aerospace and defence index has skyrocketed, as investors reposition for what is now an undeniable reality: defence spending is set to climb for years to come.

 

He says: "With European leaders scrambling to reinforce their military capabilities after the US distanced itself from security commitments, defense companies stand to be major beneficiaries.

 

"We believe that this is likely to be the beginning of a fundamental realignment that will shape markets for the foreseeable future.

 

"The shift is structural. Governments across Europe are coming to terms with the fact that their decades-long reliance on US military backing can no longer be taken for granted.

 

"The Trump administration's refusal to provide clear security guarantees has made it clear that Europe must shoulder more of the burden itself. This will translate into significant, sustained increases in defense budgets.

 

"From Asia to the Middle East, the pattern is clear: countries are prioritizing security and resilience, and the defense sector is the primary beneficiary," notes the deVere Group CEO.

 

According to a recent article quoting US defense analyst Shaun McDougall talking about Trumps’ proposed cuts, “He wants the military to focus solely on its warfighting capabilities, so the administration has begun eliminating efforts like diversity programs that he doesn’t think contribute to that warfighting mentality.”

 

Continued: “Trump’s Republican Party is actively working to increase the defense budget right now. Several key Republican lawmakers who oversee defense committees in Congress argue that the US should be raising its defense budget to at least $1 trillion. It would be hard for Trump to convince them to go the opposite direction and reduce spending by such a large amount.”

 

Behind the knee-jerk market reaction to Trump’s  news, it’s business as usual for the big defense contractors, as on January 31^st, the US Navy awarded Lockheed Martin (NYSE: LMT) a $383 million cost-plus-incentive-fee and cost-plus-fixed-fee modification to the existing Lockheed Martin contract for development of the next generation of the Trident II Strategic Weapons System (SWS) D5 missile to continue the nation's sea-based strategic deterrence.

 

For investors following defense stocks- follow the money it will tell the real story. 

 

Research aerospace and defense stocks at Investorideas.com

https://www.investorideas.com/Companies/HomelandDefense/Stock_List.asp

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all.

 

Disclaimer/Disclosure: Disclosure: this news article featuring BNIX/VisionWave is paid for content creation   on Investorideas.com (one thousand eight hundred) .Our site does not make recommendations for purchases or sale of stocks, services or products.  This is not investment opinion: Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This is not investment opinion .All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on X @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800-665-0411

 

Get more Defense Stock Investor Ideas - news, articles, and stock directories

 

Nvidia (NASDAQ: NVDA) Exceeds Expectations With Record Results and an Innovative Vision

Nvidia (NASDAQ: NVDA) Exceeds Expectations With Record Results and an Innovative Vision: Nvidia (NASDAQ: NVDA) Exceeds Expectations With Record Results and an Innovative Vision

DeepSeek and the Future of Finance: A CEO's Perspective on AI Disruption

DeepSeek and the Future of Finance: A CEO's Perspective on AI Disruption: DeepSeek and the Future of Finance: A CEO's Perspective on AI Disruption

TSX Venture AI Stock Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF) Soars on News

TSX Venture AI Stock Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF) Soars on News: TSX Venture AI Stock Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF) Soars on News

AI Stock ScanTech AI Systems Inc. (NASDAQ: STAI) Makes NASDAQ Top Gainers List on Correctional Facilities News

AI Stock ScanTech AI Systems Inc. (NASDAQ: STAI) Makes NASDAQ Top Gainers List on Correctional Facilities News: AI Stock ScanTech AI Systems Inc. (NASDAQ: STAI) Makes NASDAQ Top Gainers List on Correctional Facilities News

Investor Ideas New Stocks to Watch in Life Sciences and AI; (TSXV: $ZCT.V) (TSXV: $IOT.V) (Nasdaq: $SPRC) (OTCQB: $BIXT) (NASDAQ: $KITT) (TSX-V: $XBOT.V; OTC: $XBOTF) (OTCQB: $WYTC) (OTCQB: $RELT)

 Investor Ideas New Stocks to Watch in Life Sciences and AI; (TSXV: $ZCT.V) (TSXV: $IOT.V) (Nasdaq: $SPRC) (OTCQB: $BIXT) (NASDAQ: $KITT) (TSX-V: $XBOT.V; OTC: $XBOTF) (OTCQB: $WYTC) (OTCQB: $RELT)

 

 

February 14, 2025 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the Life Sciences and AI sectors.

 

The newest life sciences companies are involved in woman’s health, microbiology testing, cannabinoid pharmaceuticals and drug development using AI.

 

The latest AI companies are involved in autonomous robotics, AI/sensor technology and marketing and business solutions.

 

New stocks added today: Zero Candida Technologies Inc. (TSXV:ZCT), Innovotech, Inc. (TSXV: IOT), SciSparc Ltd. (Nasdaq: SPRC), Bioxytran, Inc. (OTCQB: BIXT) Nauticus Robotics, Inc. (NASDAQ:KITT), Realbotix Corp. (TSX-V: XBOT; OTC: XBOTF), Wytec International, Inc. (OTCQB: WYTC), Onar, Inc. (OTCQB: RELT).

 

Read this in full at https://www.investorideas.com/news/2025/main/02141Stocks.asp

 

 

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

New Stocks Added to the Life Sciences/Biotech Directories:

Zero Candida Technologies Inc. (TSXV:ZCT) is a publicly traded FemTech company pioneering innovative solutions in women's health. The company is developing an AI-driven, tampon-like device that uses a therapeutic light source with a selected wave-length and intensity to effectively treat the Candida fungus with a demonstrated 99.999% success rate in POC.  Vulvo-Vaginal Candidiasis ("VVC") affects about 75% of women globally, with 138witheach year 138 million women are affected world-wide and 492 million over their lifetime. Recurrent VVC (4 or more episodes per year) is increasingly documented to become drug resistant to existing treatments, since the root cause is poorly understood and addressed.  ZCT has successfully completed a safety trial using its pre-clinical device in large animals (sheep), and is finalizing their device for human use in preparation for an upcoming clinical trial, that they secured both funding and agreements with leading hospitals in Israel and Europe for. The Company continues to grow it's global patent portfolio with applications filed in the United States, Brazil and Europe, and was recently granted a final patent in South Africa. With hybrid medicine and technology-based diagnostics, ZCT is addressing unmet needs in women's healthcare and expanding access to underserved populations, bringing the field of gynecology into the 21st century.

 

Innovotech, Inc. (TSXV: IOT) is a Canadian biotechnology company owning proprietary intellectual property, conducting contract research, and owning and providing proprietary devices for testing in multiple applications in microbiology

 

SciSparc Ltd. (Nasdaq: SPRC) is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparc’s focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol: SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer's disease and agitation; and SCI-210 for the treatment of autism and status epilepticus. The Company also owns a controlling interest in a subsidiary whose business focuses on the sale of hemp seeds’ oil-based products on the Amazon.com Marketplace.

 

Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company pioneering a library of novel complex carbohydrate structures using artificial intelligence software that interprets the Nuclear Magnetic Resonance imaging of druggable targets like the galectin fold to create a rational drug design. The leading drug candidates vetted by in vitro testing, are capable of neutralizing viruses. The peer-reviewed discovery of the galectin fold located on the spike proteins of viruses such as COVID-19, RSV, and H1N1 demonstrate there exists a conserved region on the spike in which Bioxytran’s molecules achieve virus neutralization. The extent of the carbohydrate structure’s ability to neutralize untested viruses is unknown just like the initial discovery of antibiotics last century and its ability to treat a broad spectrum of bacterial infections. Applications of this platform technology extend to the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia. The leading drug candidate, Prolectin-M, is a new class of antiviral drug designed to antagonize galectins implicated in inflammatory, fibrotic, and malignant diseases. Bioxytran’s other development programs are for pulmonary fibrosis and stroke treatment.

 

New Stocks Added to the AI/Tech Directories:

Nauticus Robotics, Inc. (NASDAQ:KITT) develops autonomous robots for the ocean industries. Autonomy requires the extensive use of sensors, artificial intelligence, and effective algorithms for perception and decision allowing the robot to adapt to changing environments. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing of related software to both the commercial and defense business sectors. Nauticus has designed and is currently testing and certifying a new generation of vehicles to reduce operational cost and gather data to maintain and operate a wide variety of subsea infrastructure. Besides a standalone service offering and forward-facing products, Nauticus' approach to ocean robotics has also resulted in the development of a range of technology products for retrofit/upgrading traditional ROV operations and other third-party vehicle platforms. Nauticus' services provide customers with the necessary data collection, analytics, and subsea manipulation capabilities to support and maintain assets while reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure.

 

Realbotix Corp. (TSX-V: XBOT; OTC: XBOTF; FSE: 76M0.F) Transcending the barrier between man and machine, Realbotix creates customizable, full-bodied, humanoids with AI integration that improve the human experience through connection, learning and play. Manufactured in the USA, Realbotix has a reputation for having the highest quality humanoid robots and the most realistic silicone skin technology. Realbotix sells humanoid products with embedded AI to enable human-like social interactions and intimate connections with humans. Our integration of hardware and AI software results in the most human looking full-sized robots on this planet. We achieve this through patented technologies that deliver human-like appearance and movements. This versatility makes our robots and their personalities customizable and programmable to suit a wide variety of use cases.

 

Wytec International, Inc. (OTCQB: WYTC) is a 5G network development company with proprietary, patent, and patent-pending AI/sensor technology designed to support gunshot detection, drug sensing technology for public safety, and distance learning solutions for schools and cities.

 

Onar, Inc. (OTCQB: RELT) is a dynamic marketing and business solutions network, currently publicly traded as Reliant Holdings, Inc. with plans to become Onar Holding Corporation in the near future. ONAR's mission is to provide unparalleled service through an integrated, AI-driven approach, leveraging its diverse brand family's strengths. Committed to honor, candor, and best-in-class results, ONAR aims to lead the industry by example, ensuring every client relationship is deeply rooted in trust and excellence.

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter (X) https://X.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

 

800 665 0411